
Hematologic Oncology Update
by Dr. Neil Love
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 5 chart positions in 5 markets.
By chart position
- 🇹🇼TW · Science#112500 to 3K
- 🇫🇮FI · Science#123500 to 3K
- 🇨🇭CH · Science#138500 to 3K
- 🇦🇷AR · Science#169500 to 3K
- 🇹🇭TH · Science#188500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1.3K to 7.5K🎙 ~2x weekly·137 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
2.5K to 15K🇹🇼20%🇫🇮20%🇨🇭20%+2 more - Active Followers
Loyal subscribers who consistently listen
750 to 4.5K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 18 epsHosts
Recent guests
Recent episodes
For Oncology Nurses: Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Proceedings from the 2026 Annual ONS Congress
Jul 16, 2026
1h 58m 26s
Novel Therapies for Non-Hodgkin Lymphoma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Jul 9, 2026
1h 57m 14s
Acute Myeloid Leukemia — Fifth Annual National General Medical Oncology Summit
Jun 28, 2026
51m 43s
Myelofibrosis and Systemic Mastocytosis — Fifth Annual National General Medical Oncology Summit
Jun 24, 2026
50m 41s
Multiple Myeloma — Fifth Annual National General Medical Oncology Summit
Jun 18, 2026
47m 05s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/16/26 | Non-Hodgkin LymphomaChronic Lymphocytic Leukemia+4 | Dr Farrukh T AwanMs Robin Klebig+1 | CD20 x CD3 Bispecific AntibodiesPolatuzumab Vedotin+5 | — | Non-Hodgkin LymphomaChronic Lymphocytic Leukemia+5 | — | 1h 58m 26s | ||
| 7/9/26 | Non-Hodgkin LymphomaCD79b-Targeted Antibody-Drug Conjugates+4 | Dr Christopher FlowersDr Matthew Lunning+2 | ASCO | — | Non-Hodgkin LymphomaCD79b+5 | — | 1h 57m 14s | ||
| 6/28/26 | Acute Myeloid LeukemiaFLT3 mutations+4 | Dr Courtney D DiNardoDr Harry Paul Erba | Acute Myeloid Leukemia | — | Acute Myeloid LeukemiaFLT3+4 | — | 51m 43s | ||
| 6/24/26 | MyelofibrosisSystemic Mastocytosis+3 | Dr Anthony M HunterDr Abdulraheem Yacoub | — | — | MyelofibrosisSystemic Mastocytosis+3 | — | 50m 41s | ||
| 6/18/26 | Multiple MyelomaChimeric Antigen Receptor T-Cell Therapy+4 | Dr Hans LeeDr Noopur Raje | — | — | Multiple MyelomaChimeric Antigen Receptor T-Cell Therapy+5 | — | 47m 05s | ||
| 6/16/26 | Chronic Lymphocytic LeukemiaManagement of Newly Diagnosed CLL+3 | Dr John N AllanDr Adam Kittai | Chronic Lymphocytic Leukemia | — | Chronic Lymphocytic LeukemiaCLL Management+3 | — | 55m 24s | ||
| 6/15/26 | Diffuse Large B-Cell LymphomaFollicular Lymphoma+5 | Dr Manali KamdarDr Krish Patel+1 | Fifth Annual National General Medical Oncology SummitDiffuse Large B-Cell Lymphoma+1 | — | Diffuse Large B-Cell LymphomaFollicular Lymphoma+5 | — | 1h 59m 30s | ||
| 5/23/26 | Bruton Tyrosine Kinase InhibitorsChronic Lymphocytic Leukemia+3 | Dr Jennifer R BrownProf Wojciech Jurczak | Bruton tyrosine kinase-targeted therapyChronic Lymphocytic Leukemia | — | Bruton Tyrosine KinaseChronic Lymphocytic Leukemia+3 | — | 58m 42s | ||
| 4/20/26 | Acute Myeloid Leukemiaclinical trials+3 | Dr Amir FathiDr Eunice S Wang | Massachusetts General HospitalRoswell Park Comprehensive Cancer Center | Boston, MassachusettsBuffalo, New York | Acute Myeloid Leukemiamenin inhibitors+3 | — | 58m 54s | ||
| 4/10/26 | CELMoDsMultiple Myeloma+3 | Dr Paul G Richardson | Dana-Farber Cancer Institute | Boston, Massachusetts | CELMoDsMultiple Myeloma+3 | — | 24m 54s | ||
| 4/1/26 | immune thrombocytopeniaBruton tyrosine kinase inhibitors+3 | Dr Hanny Al-Samkari | Bruton tyrosine kinase inhibitorsBAFF-R antagonists+1 | — | immune thrombocytopeniaBruton tyrosine kinase inhibitors+3 | — | 24m 50s | ||
| 3/23/26 | CELMoDsMultiple Myeloma+3 | Dr Paul G Richardson | Dana-Farber Cancer Institute | Boston, Massachusetts | CELMoDsMultiple Myeloma+3 | — | 24m 29s | ||
| 3/21/26 | immune thrombocytopeniaBruton tyrosine kinase inhibitors+3 | Dr Hanny Al-Samkari | Bruton tyrosine kinase inhibitorsBAFF-R antagonists+1 | — | immune thrombocytopeniaBruton tyrosine kinase inhibitors+5 | — | 29m 16s | ||
| 3/13/26 | Acute Lymphoblastic LeukemiaBiTEs+3 | Dr Bijal Shah | Moffitt Cancer Center | Tampa, Florida | BiTEsAcute Lymphoblastic Leukemia+3 | — | 1h 03m 21s | ||
| 3/11/26 | Chronic Lymphocytic LeukemiaManagement+3 | Prof Constantine Tam | Monash University | — | Chronic Lymphocytic LeukemiaASH Annual Meeting+3 | — | 47m 10s | ||
| 3/9/26 | immune thrombocytopeniaBruton tyrosine kinase inhibitors+3 | Dr Hanny Al-Samkari | Bruton tyrosine kinase inhibitorsBAFF-R antagonists+1 | — | immune thrombocytopeniaBruton tyrosine kinase inhibitors+3 | — | 19m 21s | ||
| 3/4/26 | immune thrombocytopeniaBruton tyrosine kinase inhibitors+4 | Dr Hanny Al-Samkari | Bruton tyrosine kinase inhibitorsBAFF-R antagonists+1 | — | immune thrombocytopeniaBruton tyrosine kinase inhibitors+4 | — | 24m 25s | ||
| 2/18/26 | multiple myelomaCereblon E3 ligase modulators+3 | Dr Natalie S CallanderDr Paul G Richardson | CELMoDsUniversity of Wisconsin Carbone Cancer Center+1 | — | multiple myelomaCELMoDs+3 | — | 57m 58s |
Showing 18 of 18
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Similar Audience Demographics
Podcasts that attract a similar listener profile
Chart history for Hematologic Oncology Update
Peaked at #112 in TW, currently #112 in TW.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| TW | — | #112 | #112 | — |
| Finland | — | #123 | #123 | — |
| CH | — | #138 | #138 | — |
| AR | — | #169 | #169 | — |
| TH | — | #188 | #188 | — |
Chart Positions
5 placements across 5 markets.
Chart Positions
5 placements across 5 markets.